RecruitingNCT03793257

The EXCEL Registry of Patients Requiring ECMO

The EXCEL Registry: A Comprehensive Binational Registry on the Treatment and Outcomes of Patients Requiring ECMO


Sponsor

Australian and New Zealand Intensive Care Research Centre

Enrollment

3,000 participants

Start Date

Feb 1, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

ECMO is associated with significant costs, risks and requires specialist training and expertise. EXCEL is a novel, high-quality, detailed prospective registry of patients requiring ECMO in Australia and New Zealand. The registry provides information on patient selection, complications, costs and patient reported outcome measures. EXCEL uses the Theoretical Domains Framework to identify evidence-practice gaps and explore barriers and enablers to tailor implementation of evidence


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry study collecting clinical data on adult patients in Australia and New Zealand who receive ECMO — extracorporeal membrane oxygenation — a life-support machine that temporarily takes over the work of the heart and/or lungs when they are too damaged or sick to function on their own. ECMO is used in critically ill patients, including those in cardiac arrest, with severe respiratory failure, or post-heart surgery. By building a comprehensive registry of ECMO patients and their outcomes across participating hospitals, researchers aim to improve how this life-saving but complex technology is used. **You may be eligible if...** - You are an adult patient admitted to a hospital in Australia or New Zealand - You receive ECMO support during your hospital stay at a participating institution **You may NOT be eligible if...** - There are no listed exclusion criteria — if you received ECMO at a participating hospital, you qualify to be included in this registry Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(29)

Canberra Hospital

Canberra, Australian Capital Territory, Australia

Royal Prince Alfred Hospital

Camperdown, New South Wales, Australia

St Vincent's Hospital Sydney

Darlinghurst, New South Wales, Australia

Liverpool Hospital

Liverpool, New South Wales, Australia

John Hunter Hospital

Newcastle, New South Wales, Australia

Royal North Shore Hospital

St Leonards, New South Wales, Australia

Prince of Wales Hospital

Sydney, New South Wales, Australia

St George Hospital

Sydney, New South Wales, Australia

Westmead Hospital

Westmead, New South Wales, Australia

Royal Brisbane and Women's Hospital

Brisbane, Queensland, Australia

Princess Alexandra Hospital

Brisbane, Queensland, Australia

Prince Charles Hospital

Chermside, Queensland, Australia

Gold Coast University Hospital

Southport, Queensland, Australia

Sunshine Coast University Hospital

Sunshine Coast, Queensland, Australia

Townsville Hospital

Townsville, Queensland, Australia

Royal Adelaide Hosptial

Adelaide, South Australia, Australia

Flinders Medical Centre

Adelaide, South Australia, Australia

Launceston General Hospital

Launceston, Tasmania, Australia

Box Hill Hospital

Box Hill, Victoria, Australia

Monash Medical Centre

Clayton, Victoria, Australia

University Hospital Geelong

Geelong, Victoria, Australia

Austin Health

Heidelberg, Victoria, Australia

The Alfred Hospital

Melbourne, Victoria, Australia

St Vincent's Hospital Melbourne

Melbourne, Victoria, Australia

Royal Melbourne Hospital

Parkville, Victoria, Australia

Epworth Hospital

Richmond, Victoria, Australia

Sir Charles Gairdner Hospital

Nedlands, Western Australia, Australia

Fiona Stanley Hospital

Perth, Western Australia, Australia

Auckland City hospital

Auckland, New Zealand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03793257


Related Trials